The role of integrated 18F-FDG PET/CT in identification of ectopic ACTH secretion tumors

Endocrine

Volumn 36, Issue 3, 2009, Pages 385-391

  Xu, Haoping ^a   Zhang, Min ^a   Zhai, Ge ^a   Zhang, Miao ^a   Ning, Guang ^b   Li, Biao ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Cushing's syndrome; Diagnosis; Ectopic ACTH secretion

Indexed keywords

CORTICOTROPIN; FLUORODEOXYGLUCOSE F 18; HYDROCORTISONE;

ACTH SECRETING ADENOMA; AMENORRHEA; ARTICLE; BRONCHUS CARCINOID; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CLINICAL FEATURE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CORTICOTROPIN BLOOD LEVEL; CUSHING SYNDROME; DEXAMETHASONE SUPPRESSION TEST; DIAGNOSTIC ACCURACY; ECCHYMOSIS; ECTOPIC CORTICOTROPIN PRODUCTION; ELECTROLYTE DISTURBANCE; ENDOCRINE TUMOR; FATIGUE; FEMALE; HISTOPATHOLOGY; HOSPITAL ADMISSION; HUMAN; HUMAN TISSUE; HYDROCORTISONE BLOOD LEVEL; HYPERGLYCEMIA; INFECTION COMPLICATION; LABORATORY TEST; MALE; MEDIASTINUM CARCINOID; NUCLEAR MAGNETIC RESONANCE IMAGING; PNEUMONIA; PRIORITY JOURNAL; PROGNOSIS; PULMONARY CARCINOID; THYMIC CARCINOID; THYMOMA; TISSUE SECTION; TREATMENT RESPONSE; TUMOR LOCALIZATION; WEIGHT GAIN;

ACTH SYNDROME, ECTOPIC; ACTH-SECRETING PITUITARY ADENOMA; ADENOMA; ADULT; CARCINOID TUMOR; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; HYDROCORTISONE; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 70449518099     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-009-9247-2     Document Type: Article

References (20)

1. AM Isidori GA Kaltsas S Mohammed DG Morris P Jenkins SL Chew, et al. 2003 Discriminatory value of the low-dose dexamethasone suppression test in establishing the diagnosis and differential diagnosis of Cushing's syndrome J. Clin. Endocrinol. Metab. 88 5299 5306 10.1210/jc.2003-030510 1:CAS:528:DC%2BD3sXptVynsb4%3D 14602765 (Pubitemid 37452731)
2. AM Isidori GA Kaltsas C Pozza V Frajese J Newell-Price RH Reznek, et al. 2006 The ectopic adrenocorticotropin syndrome: clinical features, diagnosis, management and long-term follow-up J. Clin. Endocrinol. Metab. 91 371 377 10.1210/jc.2005-1542 1:CAS:528:DC%2BD28XhsFKnt70%3D 16303835 (Pubitemid 43236895)
3. AM Isidori A Lenzi 2007 Ectopic ACTH syndrome Arq. Bras. Endocrinol. Metabol. 51 8 1217 1225 18209859
4. JP Aniszewski WF Young Jr GB Thompson CS Grant JA van Heerden 2001 Cushing syndrome due to ectopic adrenocorticotropic hormone secretion World J. Surg. 25 7 934 940 10.1007/s00268-001-0032-5 1:STN:280:DC%2BD3MrisVGitw%3D%3D 11572035 (Pubitemid 32666396)
5. I Ilias DJ Torpy K Pacak N Mullen RA Wesley LK Nieman 2005 Cushing's syndrome due to ectopic corticotropin secretion: twenty years' experience at the National Institutes of Health J. Clin. Endocrinol. Metab. 90 4955 4962 10.1210/jc.2004-2527 1:CAS:528:DC%2BD2MXnvVWksbw%3D 15914534 (Pubitemid 41159396)
6. BM Biller AB Grossman PM Stewart S Melmed X Bertagna J Bertherat, et al. 2008 Treatment of adrenocorticotropin-dependent Cushing's syndrome: a consensus statement J. Clin. Endocrinol. Metab. 93 7 2454 2462 10.1210/jc.2007-2734 1:CAS:528:DC%2BD1cXoslyktLo%3D 18413427 (Pubitemid 352008503)
7. AM Groves HK Mohan EA Wegner SF Ham SB Bingham SE Clarke 2004 PET with FDG to show thymic carcinoid Am. J. Roentgenol. 82 511 513
8. E Gomard-Mennesson P Sève E De La Roche S Collardeau-Frachon C Lombard-Bohas C Broussolle 2008 Thymic carcinoid tumor revealed by a Cushing's syndrome: usefulness of positron emission tomography Rev. Med. Interne 29 9 751 753 10.1016/j.revmed.2008.01.007 1:STN:280:DC%2BD1crktVWqsA%3D%3D 18304700 (Epub 2008 Mar 4)
9. H Biering M Pirlich J Bauditz D Sandrock H Lochs H Gerl 2003 PET scan in occult ectopic ACTH syndrome: a useful tool? Clin. Endocrinol. 59 404 405 10.1046/j.1365-2265.2003.01853.x 1:STN:280:DC%2BD3szotlertQ%3D%3D (Pubitemid 37046997)
10. A Markou P Manning B Kaya SN Datta JB Bomanji GS Conway 2005 [18F] Fluoro-2-deoxy-D-glucose ([18F]FDG) positron emission tomography imaging of thymic carcinoid tumor presenting with recurrent Cushing's syndrome Eur. J. Endocrinol. 152 521 525 10.1530/eje.1.01839 1:CAS:528:DC%2BD2MXjslans74%3D 15817906 (Pubitemid 40575796)
11. J Kumar M Spring PV Carroll SF Barrington JK Powrie 2006 18Flurodeoxyglucose positron emission tomography in the localization of ectopic ACTH-secreting neuroendocrine tumours Clin. Endocrinol. 64 371 374 1:STN:280:DC%2BD287pvVKntw%3D%3D
12. A.B. Moraes, G.F. Taboada, M.P. Carneiro, L.V. Neto, L.E. Wildemberg, K. Madi, et al., Utility of [18F] fluoro-2-deoxy-D-glucose positron emission tomography in the localization of ectopic ACTH-secreting tumors. Pituitary, 2008 May 6. (Epub ahead of print)
13. S Adams R Baum T Rink PM Schumm-Dräger KH Usadel G Hör 1998 Limited value of fluorine-18 fluorodeoxyglucose positron emission tomography for the imaging of neuroendocrine tumours Eur. J. Nucl. Med. 25 1 79 83 10.1007/s002590050197 1:CAS:528:DyaK2sXnvVGru7o%3D 9396878 (Pubitemid 28107907)
14. JJ Erasmus HP McAdams EF Patz Jr RE Coleman V Ahuja PC Goodman 1998 Evaluation of primary pulmonary carcinoid tumors using FDG PET Am. J. Roentgenol. 170 1369 1373 1:STN:280:DyaK1c3jtlyjtw%3D%3D
15. C Le Rest JB Bomanji DC Costa CE Townsend D Visvikis PJ Ell 2001 Functional imaging of malignant paragangliomas and carcinoid tumours Eur. J. Nucl. Med. 28 478 482 10.1007/s002590100475 11357498 (Pubitemid 32260914)
16. VT de Montpreville P Macchiarini E Dulmet 1996 Thymic neuroendocrine carcinoma (carcinoid): a clinicopathologic study of fourteen cases J. Thorac. Cardiovasc. Surg. 111 134 141 10.1016/S0022-5223(96)70409-9 8551758 (Pubitemid 26035180)
17. S Adams RP Baum A Hertel PM Schumm-Drager KH Usadel G Hor 1998 Metabolic (PET) and receptor (SPET) imaging of well- and less well-differentiated tumours: comparison with the expression of the Ki-67 antigen Nucl. Med. Commun. 19 641 647 10.1097/00006231-199807000-00005 1:STN:280:DyaK1M%2FntVCmtA%3D%3D 9853344
18. C Pasquali D Rubello C Sperti P Gasparoni G Liessi F Chierichetti G Ferlin S Pedrazzoli 1998 Neuroendocrine tumor imaging: can 18F- fluorodeoxyglucose positron emission tomography detect tumors with poor prognosis and aggressive behavior? World J. Surg. 22 588 592 10.1007/s002689900439 1:STN:280:DyaK1c3mtVahtg%3D%3D 9597933 (Pubitemid 28215437)
19. M Okumura M Ohta H Tateyama, et al. 2002 The World Health Organization histologic classification system reflects the oncologic behavior of thymoma: a clinical study of 273 patients Cancer 94 3 624 632 10.1002/cncr.10226 11857293 (Pubitemid 34132289)
20. K Pacak I Ilias CC Chen JA Carrasquillo M Whatley LK Nieman 2004 The role of 18F flourodeoxyglucose positron emission tomography and 111In- diethylenetriaminepentaacetate-D-phe-pentreotide scintigraphy in the localisation of ectopic adrenocorticotropin-secreting tumours causing Cushing's syndrome J. Clin. Endocrinol. Metab. 89 2214 2221 10.1210/jc.2003-031812 1:CAS:528:DC%2BD2cXjvFyrt7s%3D 15126544 (Pubitemid 38619855)